DIMENSIONAL FUND ADVISORS LP

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 354204 AUSTIN, TX

Position in ZVRA

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$5,170,753

+$3,786,739 QoQ

Shares Held

554,802

+259.2% QoQ

Ownership

0.939%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 89.90594842844834.ToString("F0")% Shared 7.680217446945036.ToString("F0")% None 2.4138341246066166.ToString("F0")%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. ZVRA ranks #92 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,170,753	554,802	+259.2%	Shares	Sole	2026-05-07
2025-12-31	$1,384,014	154,466	+522.8%	Shares	Sole	2026-02-12
2024-09-30	$172,112	24,800	-4.4%	Shares	Sole	2024-11-07
2024-06-30	$127,125	25,944	0.0%	Shares	Sole	2024-08-09
2024-03-31	$150,475	25,944	-40.5%	Shares	Sole	2024-05-10
2023-12-31	$285,612	43,605	-19.1%	Shares	Sole	2024-02-07
2023-09-30	$259,748	53,890	+0.0%	Shares	Sole	2023-11-09
2023-06-30	$274,797	53,882	0.0%	Shares	Sole	2023-08-09
2023-03-31	$296,351	53,882	+2.2%	Shares	Sole	2023-05-12
2022-12-31	$242,066	52,738	+0.0%	Shares	Sole	2023-02-09
2022-09-30	$328,985	52,722	+2.1%	Shares	Sole	2022-11-10
2022-06-30	$230,394	51,658	—	Shares	Sole	2022-08-12
No filing history on record for this holder in this stock.